Catheter Ablation in Congenital Heart Disease: French National Prospective Registry
Catheter Ablation in Congenital Heart Disease: French National Prospective Registry
Arrhythmias represent one of the main late complications in patients with congenital heart
 disease. Atrial arrhythmias are associated with a significant morbidity and are the first
 cause of urgent hospitalization, and sudden death from ventricular arrhythmias is a leading
 cause of death in this population.

 The exponential increase of the number of patients with congenital heart disease and the
 improvement of ablative technologies are associated with a significant increase of the number
 of catheter ablation procedures.

 Most of available studies are retrospective or include a limited number of patients.

 The aim of this study is to assess the efficacy of catheter ablation in patients with
 congenital heart disease through a national prospective registry. Secondary objectives are i)
 to identify factors associated with catheter ablation efficacy in different cardiac defects,
 ii) to describe complications associated with catheter ablation in this specific population,
 and iii) to assess the impact of catheter ablation on quality of life of patients with
 congenital heart disease.
Inclusion Criteria:

 -  All patients with congenital heart disease referred for catheter ablation

 Exclusion Criteria:

 -  Absence of patient's consent

 -  Patient under guardianship or curatorship

 -  Pregnant woman